iShares Biotechnology ETF
859 hedge funds and large institutions have $7.65B invested in iShares Biotechnology ETF in 2021 Q2 according to their latest regulatory filings, with 96 funds opening new positions, 278 increasing their positions, 257 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% less capital invested
Capital invested by funds: $7.66B → $7.65B (-$11.3M)
2% less call options, than puts
Call options by funds: $497M | Put options by funds: $510M
5.93% less ownership
Funds ownership: 76.63% → 70.69% (-5.9%)
Holders
859
Holding in Top 10
13
Calls
$497M
Puts
$510M
Top Buyers
| 1 | +$82.3M | |
| 2 | +$81.8M | |
| 3 | +$54.1M | |
| 4 |
Twin Tree Management
Dallas,
Texas
|
+$52.3M |
| 5 |
Millennium Management
New York
|
+$44.4M |
Top Sellers
| 1 | -$441M | |
| 2 | -$213M | |
| 3 | -$209M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$163M |
| 5 |
JPMorgan Chase & Co
New York
|
-$104M |